See more : Sunshine Gold Limited (SHN.AX) Income Statement Analysis – Financial Results
Complete financial analysis of The Joint Corp. (JYNT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Joint Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Nuvalent, Inc. (NUVL) Income Statement Analysis – Financial Results
- KinerjaPay Corp. (KPAY) Income Statement Analysis – Financial Results
- Touchstone Exploration Inc. (PBEGF) Income Statement Analysis – Financial Results
- Zhejiang Yonggui Electric Equipment Co., Ltd. (300351.SZ) Income Statement Analysis – Financial Results
- Grupo Vasconia, S.A.B. (VASCONI.MX) Income Statement Analysis – Financial Results
The Joint Corp. (JYNT)
About The Joint Corp.
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 117.70M | 101.91M | 81.19M | 58.68M | 48.45M | 31.79M | 25.16M | 20.52M | 13.84M | 7.12M | 5.96M | 2.78M |
| Cost of Revenue | 10.55M | 9.83M | 8.51M | 6.51M | 5.57M | 4.31M | 3.31M | 2.94M | 2.82M | 2.25M | 2.01M | 1.09M |
| Gross Profit | 107.15M | 92.08M | 72.68M | 52.18M | 42.88M | 27.48M | 21.85M | 17.58M | 11.02M | 4.87M | 3.95M | 1.69M |
| Gross Profit Ratio | 91.04% | 90.35% | 89.51% | 88.91% | 88.51% | 86.44% | 86.84% | 85.68% | 79.62% | 68.43% | 66.33% | 60.84% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 343.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 81.47M | 67.99M | 49.12M | 36.20M | 30.54M | 20.30M | 18.12M | 22.10M | 15.37M | 5.10M | 2.66M | 2.24M |
| Selling & Marketing | 16.54M | 13.96M | 11.42M | 7.80M | 6.91M | 4.82M | 4.47M | 4.42M | 3.69M | 1.19M | 781.26K | 748.92K |
| SG&A | 98.01M | 81.95M | 60.55M | 44.00M | 37.46M | 25.12M | 22.59M | 26.52M | 19.06M | 6.29M | 3.44M | 2.99M |
| Other Expenses | 11.21M | 7.64M | 6.09M | 2.73M | 1.90M | -47.77K | -64.46K | 13.30K | 22.12K | -64.08K | -32.00K | 36.32K |
| Operating Expenses | 109.22M | 89.59M | 66.64M | 46.73M | 39.36M | 26.68M | 24.61M | 29.09M | 20.33M | 6.50M | 3.51M | 3.04M |
| Cost & Expenses | 119.77M | 99.42M | 75.15M | 53.24M | 44.92M | 30.99M | 27.92M | 32.03M | 23.15M | 8.74M | 5.52M | 4.13M |
| Interest Income | 0.00 | 133.10K | 69.88K | 79.48K | 61.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 67.46K | 953.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 8.58M | 6.65M | 6.09M | 2.73M | 1.90M | 1.56M | 2.02M | 2.57M | 1.27M | 210.12K | 70.73K | 49.81K |
| EBITDA | 9.14M | 7.89M | 12.16M | 8.18M | 5.43M | 2.29M | -896.78K | -8.85M | -7.76M | -1.42M | 510.51K | -1.30M |
| EBITDA Ratio | 7.77% | 10.34% | 14.98% | 13.84% | 11.40% | 9.10% | -1.28% | -26.39% | -60.05% | -19.91% | 8.57% | -46.58% |
| Operating Income | -2.07M | 2.90M | 6.01M | 5.49M | 3.41M | 205.11K | -3.17M | -15.02M | -9.32M | -1.63M | 439.79K | -1.35M |
| Operating Income Ratio | -1.76% | 2.84% | 7.40% | 9.36% | 7.05% | 0.65% | -12.62% | -73.20% | -67.34% | -22.86% | 7.38% | -48.37% |
| Total Other Income/Expenses | 3.71M | -133.10K | -187.33K | -79.48K | -42.22K | -33.59K | -64.46K | -1.47K | 283.27K | -64.08K | -32.00K | 36.32K |
| Income Before Tax | 1.64M | 1.94M | 5.94M | 5.41M | 3.37M | 215.36K | -3.24M | -15.01M | -9.03M | -1.69M | 407.79K | -1.31M |
| Income Before Tax Ratio | 1.39% | 1.91% | 7.31% | 9.22% | 6.96% | 0.68% | -12.87% | -73.13% | -65.29% | -23.76% | 6.84% | -47.07% |
| Income Tax Expense | 11.39M | 766.51K | -1.22M | -7.75M | 48.71K | -37.73K | 35.88K | 164.43K | -235.86K | 1.34M | 252.15K | -574.53K |
| Net Income | -9.75M | 1.18M | 7.57M | 13.17M | 3.32M | 253.08K | -3.28M | -15.17M | -8.80M | -3.03M | 155.64K | -736.30K |
| Net Income Ratio | -8.29% | 1.16% | 9.32% | 22.44% | 6.86% | 0.80% | -13.02% | -73.93% | -63.59% | -42.59% | 2.61% | -26.44% |
| EPS | -0.66 | 0.08 | 0.46 | 0.94 | 0.24 | 0.02 | -0.25 | -1.20 | -0.88 | -0.56 | 0.02 | -0.08 |
| EPS Diluted | -0.66 | 0.08 | 0.44 | 0.90 | 0.23 | 0.02 | -0.25 | -1.20 | -0.88 | -0.56 | 0.02 | -0.08 |
| Weighted Avg Shares Out | 14.69M | 14.49M | 14.32M | 14.00M | 13.82M | 13.67M | 13.20M | 12.64M | 10.00M | 5.41M | 9.17M | 9.17M |
| Weighted Avg Shares Out (Dil) | 14.69M | 14.87M | 14.94M | 14.58M | 14.47M | 14.03M | 13.25M | 12.70M | 10.04M | 5.45M | 9.17M | 9.17M |
SXG Acquires Remaining 30% of the Redcastle Gold-Antimony Joint Venture
VANCOUVER, BC / ACCESSWIRE / October 25, 2024 / Mawson Gold Limited ("Mawson" or the "Company") (TSXV:MAW)(Frankfurt:MXR)(OTC PINK:MWSNF) announces Southern Cross Gold Ltd. ("Southern Cross Gold" or "SXG") has entered into a Sale and Purchase Agreement (the "Agreement") with Nagambie...
Epsilon Announces Entry Into the Province of Alberta Through Two Joint Ventures
HOUSTON, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported the signing of definitive agreements to form a joint venture in the Garrington and Harmattan areas of Alberta, Canada, in the Western...
AuditBoard and Protiviti Streamline Audit Lifecycle Management with Joint Capabilities
Companies announce expansion to technology alliance at Audit & Beyond Conference in Las Vegas LAS VEGAS , Oct. 24, 2024 /PRNewswire/ -- AuditBoard, the leading cloud-based platform transforming audit, risk, and compliance management, and Protiviti , a global consulting firm...
AuditBoard and Protiviti Streamline Audit Lifecycle Management With Joint Capabilities
LAS VEGAS--(BUSINESS WIRE)--AuditBoard, the leading cloud-based platform transforming audit, risk, and compliance management, and Protiviti, a global consulting firm with market-leading expertise in internal audit, today announced new joint capabilities at Audit & Beyond, the premier event for audit, risk,...
PlantX Life Inc. Announces Joint Venture with LIV3 to Launch SugarShield Supplement Addressing the USD 5.24 Billion Weight Loss Management Supplement Market
VANCOUVER, BC , Oct. 24, 2024 /PRNewswire/ -- PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) ("PlantX" or the "Company"), a pioneer in building strong communities and operating innovative experiential online and in-store platforms that make it easier for...
The Joint Corp. to Host Conference Call on Thursday, November 7th to Discuss Third Quarter 2024 Results
SCOTTSDALE, Ariz., Oct. 24, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, announced it will report its third quarter 2024 financial results on Thursday, November 7, 2024, after the market...
Macedonian Thrace Brewery: Amsterdam District Court Finds Heineken N.V. Joint and Severally Liable for the Market Abuses of its Greek Subsidiary
AMSTERDAM--(BUSINESS WIRE)-- #EUlaw--Groundbreaking verdict places responsibility on Heineken for anticompetitive conduct of subsidiary.
Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome
BOSTON and LONDON, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) and Axovia Therapeutics Ltd. today announced a joint research collaboration designed to advance the understanding of Bardet-Biedl syndrome (BBS).
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi" or the "Company") (NASDAQ:KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or...
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Joint Stock Company Kaspi.kz AO for potential violations of federal securities laws
NEW YORK , Oct. 23, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating potential securities claims on behalf of purchasers of the American Depositary Shares...
Source: https://incomestatements.info
Category: Stock Reports